Isotretinoin for Acne
- 17 October 1985
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 313 (16) , 1013-1014
- https://doi.org/10.1056/nejm198510173131608
Abstract
The report in 1979 by Peck et al. that treatment of severe, therapy-resistant acne with oral isotretinoin (13-cis-retinoic acid) effected complete remission of the disease evoked much excitement and eager expectation.1 A particularly striking observation was that patients given this synthetic vitamin A derivative remained free of disease for prolonged periods after the completion of a course of treatment lasting four to five months. This was in contradistinction to the effect of traditional acne therapies that ordinarily require long-term use for suppression.Since September 1982, when oral isotretinoin was first marketed for use in the United States, more . . .Keywords
This publication has 9 references indexed in Scilit:
- Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for AcneNew England Journal of Medicine, 1985
- Retinoic Acid EmbryopathyNew England Journal of Medicine, 1985
- IsotretinoinDrugs, 1984
- Isotretinoin therapy for acne: Results of a multicenter dose-response studyJournal of the American Academy of Dermatology, 1984
- Changes in Plasma Cholesterol and Triglyceride Levels After Treatment With Oral IsotretinoinArchives of Dermatology, 1983
- Isotretinoin treatment of acne and related disorders: An updateJournal of the American Academy of Dermatology, 1983
- TERATOGENICITY OF ISOTRETINOINThe Lancet, 1983
- Retinoid HyperostosisNew England Journal of Medicine, 1983
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979